Articles

Dyne Articles

September 28, 2020Boston CitybizlistNews

Dyne Therapeutics Closes IPO

September 21, 2020MarketScreenerNews

Dyne Therapeutics Announces Closing of Initial Public Offering

(marketscreener.com) WALTHAM, Mass., Sept. 21, 2020 -- Dyne Therapeutics, Inc. , a muscle disease com... See more »
September 21, 2020BioSpaceNews

Dyne Therapeutics Announces Closing of Initial Public Offering

Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-... See more »
September 18, 2020BizjournalsNews

Dyne raises $233M in 19th Mass. IPO this year

Amid a parade of upsized biotech IPOs this year, a Waltham company working on drugs to treat muscle d... See more »
September 18, 2020XconomyNews

Dyne's Upsized IPO Brings In $233M for Muscle Disorders Drug R&D

Dyne Therapeutics, a company developing genetic medicines for rare muscular disorders, has raised $23... See more »
September 17, 2020Venture Capital JournalNews

VC-backed Dyne Therapeutics goes public

Dyne Therapeutics Inc, a muscle disease company, has raised about $233 million for its IPO after pric... See more »
September 17, 2020BenzingaNews

Dyne Therapeutics Announces Pricing of Initial Public Offering

WALTHAM, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a muscle dis... See more »
September 14, 2020Boston CitybizlistNews

Dyne Therapeutics Readies $175 Million IPO

Loading interface...
Loading interface...
Loading interface...
Loading interface...